<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.mdpi.com/rss/journal/biomolecules">
		<title>Biomolecules</title>
		<link>http://www.mdpi.com/journal/biomolecules</link>
		<description>Latest open access articles published in Biomolecules at http://www.mdpi.com/journal/biomolecules</description>
								<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/2/303" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/2/287" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/2/270" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/242" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/226" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/198" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/180" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/168" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/157" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/143" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/124" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/108" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/85" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/75" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/72" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/39" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/18" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/3/1/1" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/635" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/622" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/608" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/579" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/564" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/549" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/524" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/505" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/483" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/467" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/435" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/4/415" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/3/389" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/3/376" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/3/350" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/3/331" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/3/312" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/288" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/282" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/269" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/256" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/240" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/228" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/203" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/2/187" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/165" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/143" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/122" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/104" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/76" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/46" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/34" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/23" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/2/1/1" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/1/1/48" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/1/1/32" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/1/1/3" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2218-273X/1/1/1" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>

        <item rdf:about="http://www.mdpi.com/2218-273X/3/2/303">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 303-315: Sphingosine 1-Phosphate and Cancer: Lessons from Thyroid Cancer Cells]]></title>
	<link>http://www.mdpi.com/2218-273X/3/2/303</link>
	<description>Sphingomyelin is found in the cell membrane of all eukaryotic cells, and was for a long time considered merely as a structural component. However, during the last two decades, metabolites of sphingomyelin, especially sphingosine 1-phosphate (S1P), have proven to be physiologically significant regulators of cell function. Through its five different G protein-coupled receptors, S1P regulates a wide array of cellular processes, ranging from stimulating cellular proliferation and migration, to the inhibition of apoptosis and induction of angiogenesis and modulation of cellular calcium homeostasis. Many of the processes regulated by S1P are important for normal cell physiology, but may also induce severe pathological conditions, especially in malignancies like cancer. Thus, understanding S1P signaling mechanisms has been the aim of a multitude of investigations. Great interest has also been shown in understanding the action of sphingosine kinase (SphK), i.e., the kinase phosphorylating sphingosine to S1P, and the interactions between S1P and growth factor signaling. In the present review, we will discuss recent findings regarding the possible importance of S1P and SphK in the etiology of thyroid cancer. Although clinical data is still scarce, our in vitro findings suggest that S1P may function as a “double-edged sword”, as the receptor profile of thyroid cancer cells largely determines whether S1P stimulates or blocks cellular migration. We will also discuss the interactions between S1P- and VEGF-evoked signaling, and the importance of a S1P1-VEGF receptor 2 complex in thyroid cancer cells.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-05-14</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3020303</prism:doi>
	<prism:startingPage>303</prism:startingPage>
		<prism:endingPage>315</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Sphingosine 1-Phosphate and Cancer: Lessons from Thyroid Cancer Cells]]></dc:title>
    <dc:date>2013-05-14</dc:date>
	<dc:identifier>doi: 10.3390/biom3020303</dc:identifier>
    	<dc:creator>Kid Törnquist</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/2/287">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 287-302: Single Nucleotide Polymorphisms Associated with  MicroRNA Regulation]]></title>
	<link>http://www.mdpi.com/2218-273X/3/2/287</link>
	<description>Since the discovery of microRNA (miRNA), the polymorphisms that affect miRNA regulation had been extensively investigated by many independent studies. Recently, researchers utilized bioinformatics and statistical approaches for genome-wide analysis on the human polymorphisms that reside in the miRNA genes, targets, and/or genes involved in miRNA processing. In this review, we will give an overview about the important findings of these studies from three perspectives: architecture of the polymorphisms within miRNAs or their targets, potential functional consequences of the polymorphisms on miRNA processing or targeting, and the associations of the polymorphisms with miRNA or target gene expression. The results of the previous studies demonstrated the signatures of natural selections on the miRNA genes and their targets, and proposed a collection of potentially functional, expression-associated, and/or positively selected polymorphisms that are promising for further investigations. In the meantime, a few useful resources about the polymorphic miRNA regulation have been developed and the different features of these databases were discussed in this review. Though recent research had benefited from these comprehensive studies and resources, there were still gaps in our knowledge about the polymorphisms involved in miRNA regulation, and future investigations were expected to address these questions.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-04-09</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3020287</prism:doi>
	<prism:startingPage>287</prism:startingPage>
		<prism:endingPage>302</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Single Nucleotide Polymorphisms Associated with  MicroRNA Regulation]]></dc:title>
    <dc:date>2013-04-09</dc:date>
	<dc:identifier>doi: 10.3390/biom3020287</dc:identifier>
    	<dc:creator>Yu Jin</dc:creator>
		<dc:creator>Caroline Lee</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/2/270">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 270-286: Overcoming Challenges and Opening New Opportunities  in Glycoproteomics]]></title>
	<link>http://www.mdpi.com/2218-273X/3/2/270</link>
	<description>Glycoproteomics has emerged as a prime area of interest within the field of proteomics because glycoproteins have been shown to function as biomarkers for disease and as promising therapeutic targets. A significant challenge in the study of glycoproteins is the fact that they are expressed in relatively low abundance in cells. In response, various enrichment methods have been developed to improve the detection of glycoproteins. One such method involves their capture via oxidation of their glycan chains and covalent attachment with hydrazide resins which, when catalyzed by PNGase F, release N-linked glycans and convert the glycosite Asn to Asp; this conversion is identifiable with LC/ESI-MS/MS as a corresponding increase of 0.984 Da in molecular weight. The present study builds on this body of work, providing evidence of three additional strategies that improve glycoprotein identification: (1) use of a high resolution mass spectrometer—the Q Exactive MS—which delivers 2–3 times more glycoprotein identifications than a low resolution MS; (2) optimization of instrument settings and database search parameters to reduce misidentification of N-linked glycopeptides to ~1 percent; and (3) labeling glycopeptides with 18O during PNGase F treatment to locate N-linked glycosites within peptides containing multiple N-linked sequons.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-03-26</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3020270</prism:doi>
	<prism:startingPage>270</prism:startingPage>
		<prism:endingPage>286</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Overcoming Challenges and Opening New Opportunities  in Glycoproteomics]]></dc:title>
    <dc:date>2013-03-26</dc:date>
	<dc:identifier>doi: 10.3390/biom3020270</dc:identifier>
    	<dc:creator>Ten-Yang Yen</dc:creator>
		<dc:creator>Sucharita Dutta</dc:creator>
		<dc:creator>Christina Litsakos-Cheung</dc:creator>
		<dc:creator>Alejandro Corona</dc:creator>
		<dc:creator>Leslie Timpe</dc:creator>
		<dc:creator>Bruce Macher</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/242">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 242-269: Morphological and Functional Analysis of Hepatocyte Spheroids Generated on Poly-HEMA-Treated Surfaces under the Influence of Fetal Calf Serum and Nonparenchymal Cells]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/242</link>
	<description>Poly (2-hydroxyethyl methacrylate) (HEMA) has been used as a clinical material, in the form of a soft hydrogel, for various surgical procedures, including endovascular surgery of liver. It is a clear liquid compound and, as a soft, flexible, water-absorbing material, has been used to make soft contact lenses from small, concave, spinning molds. Primary rat hepatocyte spheroids were created on a poly-HEMA-coated surface with the intention of inducing hepatic tissue formation and improving liver functions. We investigated spheroid formation of primary adult rat hepatocyte cells and characterized hepatic-specific functions under the special influence of fetal calf serum (FCS) and nonparencymal cells (NPC) up to six days in different culture systems (e.g., hepatocytes + FCS, hepatocytes – FCS, NPC + FCS, NPC – FCS, co-culture + FCS, co-culture – FCS) in both the spheroid model and sandwich model. Immunohistologically, we detected gap junctions, Ito cell/Kupffer cells, sinusoidal endothelial cells and an extracellular matrix in the spheroid model. FCS has no positive effect in the sandwich model, but has a negative effect in the spheroid model on albumin production, and no influence in urea production in either model. We found more cell viability in smaller diameter spheroids than larger ones by using the apoptosis test. Furthermore, there is no positive influence of the serum or NPC on spheroid formation, suggesting that it may only depend on the physical condition of the culture system. Since the sandwich culture has been considered a “gold standard” in vitro culture model, the hepatocyte spheroids generated on the poly-HEMA-coated surface were compared with those in the sandwich model. Major liver-specific functions, such as albumin secretion and urea synthesis, were evaluated in both the spheroid and sandwich model. The synthesis performance in the spheroid compared to the sandwich culture increases approximately by a factor of 1.5. Disintegration of plasma membranes in both models was measured by lactate dehydrogenase (LDH) release in both models. Additionally, diazepam was used as a substrate in drug metabolism studies to characterize the differences in the biotransformation potential with metabolite profiles in both models. It showed that the diazepam metabolism activities in the spheroid model is about 10-fold lower than the sandwich model. The poly-HEMA-based hepatocyte spheroid is a promising new platform towards hepatic tissue engineering leading to in vitro hepatic tissue formation.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-03-07</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010242</prism:doi>
	<prism:startingPage>242</prism:startingPage>
		<prism:endingPage>269</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Morphological and Functional Analysis of Hepatocyte Spheroids Generated on Poly-HEMA-Treated Surfaces under the Influence of Fetal Calf Serum and Nonparenchymal Cells]]></dc:title>
    <dc:date>2013-03-07</dc:date>
	<dc:identifier>doi: 10.3390/biom3010242</dc:identifier>
    	<dc:creator>Ali Acikgöz</dc:creator>
		<dc:creator>Shibashish Giri</dc:creator>
		<dc:creator>Man-Gi Cho</dc:creator>
		<dc:creator>Augustinus Bader</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/226">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 226-241: Panning for Long Noncoding RNAs]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/226</link>
	<description>The recent advent of high-throughput approaches has revealed widespread transcription of the human genome, leading to a new appreciation of transcription regulation, especially from noncoding regions. Distinct from most coding and small noncoding RNAs, long noncoding RNAs (lncRNAs) are generally expressed at low levels, are less conserved and lack protein-coding capacity. These intrinsic features of lncRNAs have not only hampered their full annotation in the past several years, but have also generated controversy concerning whether many or most of these lncRNAs are simply the result of transcriptional noise. Here, we assess these intrinsic features that have challenged lncRNA discovery and further summarize recent progress in lncRNA discovery with integrated methodologies, from which new lessons and insights can be derived to achieve better characterization of lncRNA expression regulation. Full annotation of lncRNA repertoires and the implications of such annotation will provide a fundamental basis for comprehensive understanding of pervasive functions of lncRNAs in biological regulation.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-28</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010226</prism:doi>
	<prism:startingPage>226</prism:startingPage>
		<prism:endingPage>241</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Panning for Long Noncoding RNAs]]></dc:title>
    <dc:date>2013-02-28</dc:date>
	<dc:identifier>doi: 10.3390/biom3010226</dc:identifier>
    	<dc:creator>Shanshan Zhu</dc:creator>
		<dc:creator>Xiao-Ou Zhang</dc:creator>
		<dc:creator>Li Yang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/198">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 198-225: Recent Advances in Cellular Glycomic Analyses]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/198</link>
	<description>A large variety of glycans is intricately located on the cell surface, and the overall profile (the glycome, given the entire repertoire of glycoconjugate-associated sugars in cells and tissues) is believed to be crucial for the diverse roles of glycans, which are mediated by specific interactions that control cell-cell adhesion, immune response, microbial pathogenesis and other cellular events. The glycomic profile also reflects cellular alterations, such as development, differentiation and cancerous change. A glycoconjugate-based approach would therefore be expected to streamline discovery of novel cellular biomarkers. Development of such an approach has proven challenging, due to the technical difficulties associated with the analysis of various types of cellular glycomes; however, recent progress in the development of analytical methodologies and strategies has begun to clarify the cellular glycomics of various classes of glycoconjugates. This review focuses on recent advances in the technical aspects of cellular glycomic analyses of major classes of glycoconjugates, including N- and O-linked glycans, derived from glycoproteins, proteoglycans and glycosphingolipids. Articles that unveil the glycomics of various biologically important cells, including embryonic and somatic stem cells, induced pluripotent stem (iPS) cells and cancer cells, are discussed.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-21</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010198</prism:doi>
	<prism:startingPage>198</prism:startingPage>
		<prism:endingPage>225</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Recent Advances in Cellular Glycomic Analyses]]></dc:title>
    <dc:date>2013-02-21</dc:date>
	<dc:identifier>doi: 10.3390/biom3010198</dc:identifier>
    	<dc:creator>Jun-ichi Furukawa</dc:creator>
		<dc:creator>Naoki Fujitani</dc:creator>
		<dc:creator>Yasuro Shinohara</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/180">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 180-197: Multi-Color Spectral Transcript Analysis (SPECTRA) for Phenotypic Characterization of Tumor Cells]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/180</link>
	<description>Many human tumors show significant changes in their signal transduction pathways and, thus, the way the cells interact with their environment. Often caused by chromosomal rearrangements, including gene amplifications, translocations or deletions, the altered levels of gene expression may provide a tumor-specific signature that can be exploited for diagnostic or therapeutic purposes. We investigated the utility of multiplexed fluorescence in situ hybridization (FISH) using non-isotopically labeled cDNA probes detected by Spectral Imaging as a sensitive and rapid procedure to measure tumor-specific gene expression signatures. We used a commercially available system to acquire and analyze multicolor FISH images. Initial investigations used panels of fluorescent calibration standards to evaluate the system. These experiments were followed by hybridization of five-to-six differently labeled cDNA probes, which target the transcripts of tyrosine kinase genes known to be differently expressed in normal cells and tumors of the breast or thyroid gland. The relatively simple, yet efficient, molecular cytogenetic method presented here may find many applications in characterization of solid tumors or disseminated tumor cells. Addressing tumor heterogeneity by means of multi-parameter single cell analyses is expected to enable a wide range of investigations in the areas of tumor stem cells, tumor clonality and disease progression.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-11</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010180</prism:doi>
	<prism:startingPage>180</prism:startingPage>
		<prism:endingPage>197</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Multi-Color Spectral Transcript Analysis (SPECTRA) for Phenotypic Characterization of Tumor Cells]]></dc:title>
    <dc:date>2013-02-11</dc:date>
	<dc:identifier>doi: 10.3390/biom3010180</dc:identifier>
    	<dc:creator>Joanne Hsu</dc:creator>
		<dc:creator>Jingly Weier</dc:creator>
		<dc:creator>Heinz-Ulrich Weier</dc:creator>
		<dc:creator>Yuko Ito</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/168">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 168-179: Soybean Hydrophobic Protein Response to External Electric Field: A Molecular Modeling Approach]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/168</link>
	<description>The molecular dynamic (MD) modeling approach was applied to evaluate the effect of an external electric field on soybean hydrophobic protein and surface properties. Nominal electric field strengths of 0.002 V/nm and 0.004 V/nm had no major effect on the structure and surface properties of the protein isolate but the higher electric field strength of 3 V/nm significantly affected the protein conformation and solvent accessible surface area. The response of protein isolate to various external field stresses demonstrated that it is necessary to gain insight into protein dynamics under electromagnetic fields in order to be able to develop the techniques utilizing them for food processing and other biological applications.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-11</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010168</prism:doi>
	<prism:startingPage>168</prism:startingPage>
		<prism:endingPage>179</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Soybean Hydrophobic Protein Response to External Electric Field: A Molecular Modeling Approach]]></dc:title>
    <dc:date>2013-02-11</dc:date>
	<dc:identifier>doi: 10.3390/biom3010168</dc:identifier>
    	<dc:creator>Ashutosh Singh</dc:creator>
		<dc:creator>Valérie Orsat</dc:creator>
		<dc:creator>Vijaya Raghavan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/157">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 157-167: MicroRNA Expression in Cystic Fibrosis Airway Epithelium]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/157</link>
	<description>MicroRNAs (miRs) have emerged as major regulators of the protein content of a cell. In the most part, miRs negatively regulate target mRNA expression, with sets of miRs predicted to regulate certain signaling pathways. The miR expression profile of endobronchial brushings is altered in people with cystic fibrosis (CF) compared to those without CF. How this impacts on CF has important implications for our growing understanding of the pathophysiology of CF lung disease and the development of new therapeutics to treat its pulmonary manifestations. Herein we discuss the potential consequences of altered miR expression in CF airway epithelium particularly with respect to cystic fibrosis transmembrane conductance regulator (CFTR) expression, innate immunity and toll-like receptor signalling and explore how best to exploit these changes for therapeutic benefit.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-11</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010157</prism:doi>
	<prism:startingPage>157</prism:startingPage>
		<prism:endingPage>167</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[MicroRNA Expression in Cystic Fibrosis Airway Epithelium]]></dc:title>
    <dc:date>2013-02-11</dc:date>
	<dc:identifier>doi: 10.3390/biom3010157</dc:identifier>
    	<dc:creator>Catherine Greene</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/143">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 143-156: Why YRNAs? About Versatile RNAs and Their Functions]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/143</link>
	<description>Y RNAs constitute a family of highly conserved small noncoding RNAs (in humans: 83-112 nt; Y1, Y3, Y4 and Y5). They are transcribed from individual genes by RNA-polymerase III and fold into conserved stem-loop-structures. Although discovered 30 years ago, insights into the cellular and physiological role of Y RNAs remains incomplete. In this review, we will discuss knowledge on the structural properties, associated proteins and discuss proposed functions of Y RNAs. We suggest Y RNAs to be an integral part of ribonucleoprotein networks within cells and could therefore have substantial influence on many different cellular processes. Putative functions of Y RNAs include small RNA quality control, DNA replication, regulation of the cellular stress response and proliferation. This suggests Y RNAs as essential regulators of cell fate and indicates future avenues of research, which will provide novel insights into the role of small noncoding RNAs in gene expression.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-08</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010143</prism:doi>
	<prism:startingPage>143</prism:startingPage>
		<prism:endingPage>156</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Why YRNAs? About Versatile RNAs and Their Functions]]></dc:title>
    <dc:date>2013-02-08</dc:date>
	<dc:identifier>doi: 10.3390/biom3010143</dc:identifier>
    	<dc:creator>Marcel Köhn</dc:creator>
		<dc:creator>Nikolaos Pazaitis</dc:creator>
		<dc:creator>Stefan Hüttelmaier</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/124">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 124-142: Regulation of Mammalian Gene Dosage by Long Noncoding RNAs]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/124</link>
	<description>Recent transcriptome studies suggest that long noncoding RNAs (lncRNAs) are key components of the mammalian genome, and their study has become a new frontier in biomedical research. In fact, lncRNAs in the mammalian genome were identified and studied at particular epigenetic loci, including imprinted loci and X-chromosome inactivation center, at least two decades ago—long before development of high throughput sequencing technology. Since then, researchers have found that lncRNAs play essential roles in various biological processes, mostly during development. Since much of our understanding of lncRNAs originates from our knowledge of these well-established lncRNAs, in this review we will focus on lncRNAs from the X-chromosome inactivation center and the Dlk1-Dio3 imprinted cluster as examples of lncRNA mechanisms functioning in the epigenetic regulation of mammalian genes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-02-04</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010124</prism:doi>
	<prism:startingPage>124</prism:startingPage>
		<prism:endingPage>142</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Regulation of Mammalian Gene Dosage by Long Noncoding RNAs]]></dc:title>
    <dc:date>2013-02-04</dc:date>
	<dc:identifier>doi: 10.3390/biom3010124</dc:identifier>
    	<dc:creator>Ko-Hsuan Hung</dc:creator>
		<dc:creator>Yang Wang</dc:creator>
		<dc:creator>Jing Zhao</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/108">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 108-123: Application of Metabolic 13C Labeling in Conjunction with High-Field Nuclear Magnetic Resonance Spectroscopy for Comparative Conformational Analysis of High  Mannose-Type Oligosaccharides]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/108</link>
	<description>High mannose-type oligosaccharides are enzymatically trimmed in the endoplasmic reticulum, resulting in various processing intermediates with exposed glycotopes that are recognized by a series of lectins involved in glycoprotein fate determination in cells. Although recent crystallographic data have provided the structural basis for the carbohydrate recognition of intracellular lectins, atomic information of dynamic oligosaccharide conformations is essential for a quantitative understanding of the energetics of carbohydrate–lectin interactions. Carbohydrate NMR spectroscopy is useful for characterizing such conformational dynamics, but often hampered by poor spectral resolution and lack of recombinant techniques required to produce homogeneous glycoforms. To overcome these difficulties, we have recently developed a methodology for the preparation of a homogeneous high mannose-type oligosaccharide with 13C labeling using a genetically engineered yeast strain. We herein successfully extended this method to result in the overexpression of 13C-labeled Man9GlcNAc2 (M9) with a newly engineered yeast strain with the deletion of four genes involved in N-glycan processing. This enabled high-field NMR analyses of 13C-labeled M9 in comparison with its processing product lacking the terminal mannose residue ManD2. Long-range NOE data indicated that the outer branches interact with the core in both glycoforms, and such foldback conformations are enhanced upon the removal of ManD2. The observed conformational variabilities might be significantly associated with lectins and glycan-trimming enzymes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-01-25</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010108</prism:doi>
	<prism:startingPage>108</prism:startingPage>
		<prism:endingPage>123</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Application of Metabolic 13C Labeling in Conjunction with High-Field Nuclear Magnetic Resonance Spectroscopy for Comparative Conformational Analysis of High  Mannose-Type Oligosaccharides]]></dc:title>
    <dc:date>2013-01-25</dc:date>
	<dc:identifier>doi: 10.3390/biom3010108</dc:identifier>
    	<dc:creator>Yukiko Kamiya</dc:creator>
		<dc:creator>Kotaro Yanagi</dc:creator>
		<dc:creator>Toshihiko Kitajima</dc:creator>
		<dc:creator>Takumi Yamaguchi</dc:creator>
		<dc:creator>Yasunori Chiba</dc:creator>
		<dc:creator>Koichi Kato</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/85">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 85-107: Binding of Sperm to the Zona Pellucida Mediated by Sperm Carbohydrate-Binding Proteins is not Species-Specific in Vitro between Pigs and Cattle]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/85</link>
	<description>Carbohydrates are candidates for the basis of species-selective interaction of gametes during mammalian fertilization. In this study, we sought to clarify the roles of sugar residues in the species-selective, sperm–oocyte interaction in pigs and cattle. Acrosome-intact porcine and bovine sperm exhibited their strongest binding affinities for β-Gal and α-Man residues, respectively. Porcine-sperm specificity changed from β-Gal to α-Man after the acrosome reaction, while bovine-sperm specificity did not. Binding of acrosome-intact and acrosome-reacted sperm decreased after trypsinization, indicating that the carbohydrate-binding components are proteins. While immature oocytes bound homologous sperm preferentially to heterologous sperm, oocytes matured in vitro bound similar numbers of homologous and heterologous sperm. Lectin staining revealed the aggregation of α-Man residues on the outer surface of the porcine zona during maturation. In both species, zona-free, mature oocytes bound homologous sperm preferentially to heterologous sperm. The lectin-staining patterns of the zona pellucida and zona-free oocytes coincided with the carbohydrate-binding specificities of acrosome-intact and acrosome-reacted sperm, respectively, supporting the involvement of carbohydrates in gamete recognition in pigs and cattle. These results also indicate that sperm-zona pellucida and sperm–oolemma bindings are not strictly species-specific in pigs and cattle, and further suggest that sperm penetration into the zona and/or fusion with oolemma may be  species-specific between pigs and cattle.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-01-25</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010085</prism:doi>
	<prism:startingPage>85</prism:startingPage>
		<prism:endingPage>107</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Binding of Sperm to the Zona Pellucida Mediated by Sperm Carbohydrate-Binding Proteins is not Species-Specific in Vitro between Pigs and Cattle]]></dc:title>
    <dc:date>2013-01-25</dc:date>
	<dc:identifier>doi: 10.3390/biom3010085</dc:identifier>
    	<dc:creator>Kazuya Takahashi</dc:creator>
		<dc:creator>Kazuhiro Kikuchi</dc:creator>
		<dc:creator>Yasuomi Uchida</dc:creator>
		<dc:creator>Saeko Kanai-Kitayama</dc:creator>
		<dc:creator>Reiichiro Suzuki</dc:creator>
		<dc:creator>Reiko Sato</dc:creator>
		<dc:creator>Kazunori Toma</dc:creator>
		<dc:creator>Masaya Geshi</dc:creator>
		<dc:creator>Satoshi Akagi</dc:creator>
		<dc:creator>Minoru Nakano</dc:creator>
		<dc:creator>Naoto Yonezawa</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/75">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 75-84: Role of the Checkpoint Clamp in DNA Damage Response]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/75</link>
	<description>DNA damage occurs during DNA replication, spontaneous chemical reactions, and assaults by external or metabolism-derived agents. Therefore, all living cells must constantly contend with DNA damage. Cells protect themselves from these genotoxic stresses by activating the DNA damage checkpoint and DNA repair pathways. Coordination of these pathways requires tight regulation in order to prevent genomic instability. The checkpoint clamp complex consists of Rad9, Rad1 and Hus1 proteins, and is often called the 9-1-1 complex. This PCNA (proliferating cell nuclear antigen)-like donut-shaped protein complex is a checkpoint sensor protein that is recruited to DNA damage sites during the early stage of the response, and is required for checkpoint activation. As PCNA is required for multiple pathways of DNA metabolism, the checkpoint clamp has also been implicated in direct roles in DNA repair, as well as in coordination of the pathways. Here we discuss roles of the checkpoint clamp in DNA damage response (DDR).</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-01-16</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010075</prism:doi>
	<prism:startingPage>75</prism:startingPage>
		<prism:endingPage>84</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Role of the Checkpoint Clamp in DNA Damage Response]]></dc:title>
    <dc:date>2013-01-16</dc:date>
	<dc:identifier>doi: 10.3390/biom3010075</dc:identifier>
    	<dc:creator>Mihoko Kai</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/72">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 72-74: Correction: Kousholt, A.N. et al. Pathways for Genome Integrity in G2 Phase of the Cell Cycle. Biomolecules 2012, 2, 579-607]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/72</link>
	<description>We have discovered an error in our paper published in Biomolecules [1], in Figure 1 on page 589. The protein names ATR and ATRIP have been swapped. A corrected version of the Figure 1 is provided below.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2013-01-15</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Correction</prism:section>
	<prism:doi>10.3390/biom3010072</prism:doi>
	<prism:startingPage>72</prism:startingPage>
		<prism:endingPage>74</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Correction: Kousholt, A.N. et al. Pathways for Genome Integrity in G2 Phase of the Cell Cycle. Biomolecules 2012, 2, 579-607]]></dc:title>
    <dc:date>2013-01-15</dc:date>
	<dc:identifier>doi: 10.3390/biom3010072</dc:identifier>
    	<dc:creator>Arne Kousholt</dc:creator>
		<dc:creator>Tobias Menzel</dc:creator>
		<dc:creator>Claus Sørensen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/39">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 39-71: Homologous Recombination as a Replication Fork Escort: Fork-Protection and Recovery]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/39</link>
	<description>Homologous recombination is a universal mechanism that allows DNA repair and ensures the efficiency of DNA replication. The substrate initiating the process of homologous recombination is a single-stranded DNA that promotes a strand exchange reaction resulting in a genetic exchange that promotes genetic diversity and DNA repair. The molecular mechanisms by which homologous recombination repairs a double-strand break have been extensively studied and are now well characterized. However, the mechanisms by which homologous recombination contribute to DNA replication in eukaryotes remains poorly understood. Studies in bacteria have identified multiple roles for the machinery of homologous recombination at replication forks. Here, we review our understanding of the molecular pathways involving the homologous recombination machinery to support the robustness of DNA replication. In addition to its role in fork-recovery and in rebuilding a functional replication fork apparatus, homologous recombination may also act as a fork-protection mechanism. We discuss that some of the fork-escort functions of homologous recombination might be achieved by loading of the recombination machinery at inactivated forks without a need for a strand exchange step; as well as the consequence of such a model for the stability of eukaryotic genomes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-27</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010039</prism:doi>
	<prism:startingPage>39</prism:startingPage>
		<prism:endingPage>71</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Homologous Recombination as a Replication Fork Escort: Fork-Protection and Recovery]]></dc:title>
    <dc:date>2012-12-27</dc:date>
	<dc:identifier>doi: 10.3390/biom3010039</dc:identifier>
    	<dc:creator>Audrey Costes</dc:creator>
		<dc:creator>Sarah Lambert</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/18">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 18-38: Comparative Ultrastructure and Carbohydrate Composition of Gastroliths from Astacidae, Cambaridae and Parastacidae Freshwater Crayfish (Crustacea, Decapoda)]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/18</link>
	<description>Crustaceans have to cyclically replace their rigid exoskeleton in order to grow. Most of them harden this skeleton by a calcification process. Some decapods (land crabs, lobsters and crayfish) elaborate calcium storage structures as a reservoir of calcium ions in their stomach wall, as so-called gastroliths. For a better understanding of the cyclic elaboration of these calcium deposits, we studied the ultrastructure of gastroliths from freshwater crayfish by using a combination of microscopic and physical techniques. Because sugars are also molecules putatively involved in the elaboration process of these biomineralizations, we also determined their carbohydrate composition. This study was performed in a comparative perspective on crayfish species belonging to the infra-order Astacidea (Decapoda, Malacostraca): three species from the Astacoidea superfamily and one species from the Parastacoidea superfamily. We observed that all the gastroliths exhibit a similar dense network of protein-chitin fibers, from macro- to nanoscale, within which calcium is precipitated as amorphous calcium carbonate. Nevertheless, they are not very similar at the molecular level, notably as regards their carbohydrate composition. Besides glucosamine, the basic carbohydrate component of chitin, we evidenced the presence of other sugars, some of which are species-specific like rhamnose and galacturonic acid whereas xylose and mannose could be linked to proteoglycan components.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-21</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom3010018</prism:doi>
	<prism:startingPage>18</prism:startingPage>
		<prism:endingPage>38</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Comparative Ultrastructure and Carbohydrate Composition of Gastroliths from Astacidae, Cambaridae and Parastacidae Freshwater Crayfish (Crustacea, Decapoda)]]></dc:title>
    <dc:date>2012-12-21</dc:date>
	<dc:identifier>doi: 10.3390/biom3010018</dc:identifier>
    	<dc:creator>Gilles Luquet</dc:creator>
		<dc:creator>María Fernández</dc:creator>
		<dc:creator>Aïcha Badou</dc:creator>
		<dc:creator>Nathalie Guichard</dc:creator>
		<dc:creator>Nathalie Roy</dc:creator>
		<dc:creator>Marion Corneillat</dc:creator>
		<dc:creator>Gérard Alcaraz</dc:creator>
		<dc:creator>José Arias</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/3/1/1">
	<title><![CDATA[Biomolecules, Vol. 3, Pages 1-17: Molecular Insights into Poly(ADP-ribose) Recognition and Processing]]></title>
	<link>http://www.mdpi.com/2218-273X/3/1/1</link>
	<description>Poly(ADP-ribosyl)ation is a post-translational protein modification involved in the regulation of important cellular functions including DNA repair, transcription, mitosis and apoptosis. The amount of poly(ADP-ribosyl)ation (PAR) in cells reflects the balance of synthesis, mediated by the PARP protein family, and degradation, which is catalyzed by a glycohydrolase, PARG. Many of the proteins mediating PAR metabolism possess specialised high affinity PAR-binding modules that allow the efficient sensing or processing of the PAR signal. The identification of four such PAR-binding modules and the characterization of a number of proteins utilising these elements during the last decade has provided important insights into how PAR regulates different cellular activities. The macrodomain represents a unique PAR-binding module which is, in some instances, known to possess enzymatic activity on ADP-ribose derivatives (in addition to PAR-binding). The most recently discovered example for this is the PARG protein, and several available PARG structures have provided an understanding into how the PARG macrodomain evolved into a major enzyme that maintains PAR homeostasis in living cells.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-21</prism:publicationDate>
	<prism:volume>3</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom3010001</prism:doi>
	<prism:startingPage>1</prism:startingPage>
		<prism:endingPage>17</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Molecular Insights into Poly(ADP-ribose) Recognition and Processing]]></dc:title>
    <dc:date>2012-12-21</dc:date>
	<dc:identifier>doi: 10.3390/biom3010001</dc:identifier>
    	<dc:creator>Roko Žaja</dc:creator>
		<dc:creator>Andreja Mikoč</dc:creator>
		<dc:creator>Eva Barkauskaite</dc:creator>
		<dc:creator>Ivan Ahel</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/635">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 635-649: Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/635</link>
	<description>Treatments with Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors have offered patients carrying cancers with mutated BRCA1 or BRCA2 genes a new and in many cases effective option for disease control. There is potentially a large patient population that may also benefit from PARP inhibitor treatment, either in monotherapy or in combination with chemotherapy. Here, we describe the multifaceted role of PARP inhibitors and discuss which treatment options could potentially be useful to gain disease control without potentiating side effects.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-14</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040635</prism:doi>
	<prism:startingPage>635</prism:startingPage>
		<prism:endingPage>649</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy]]></dc:title>
    <dc:date>2012-12-14</dc:date>
	<dc:identifier>doi: 10.3390/biom2040635</dc:identifier>
    	<dc:creator>Cecilia Ström</dc:creator>
		<dc:creator>Thomas Helleday</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/622">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 622-634: Decorin Content and Near Infrared Spectroscopy Analysis of Dried Collagenous Biomaterial Samples]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/622</link>
	<description>The efficient removal of proteoglycans, such as decorin, from the hide when processing it to leather by traditional means is generally acceptable and beneficial for leather quality, especially for softness and flexibility. A patented waterless or acetone dehydration method that can generate a product similar to leather called Dried Collagenous Biomaterial (known as BCD) was developed but has no effect on decorin removal efficiency. The Alcian Blue colorimetric technique was used to assay the sulfated glycosaminoglycan (sGAG) portion of decorin. The corresponding residual decorin content was correlated to the mechanical properties of the BCD samples and was comparable to the control leather made traditionally. The waterless dehydration and instantaneous chrome tanning process is a good eco-friendly alternative to transforming hides to leather because no additional effects were observed after examination using NIR spectroscopy and additional chemometric analysis.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-14</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2040622</prism:doi>
	<prism:startingPage>622</prism:startingPage>
		<prism:endingPage>634</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Decorin Content and Near Infrared Spectroscopy Analysis of Dried Collagenous Biomaterial Samples]]></dc:title>
    <dc:date>2012-12-14</dc:date>
	<dc:identifier>doi: 10.3390/biom2040622</dc:identifier>
    	<dc:creator>Mila Aldema-Ramos</dc:creator>
		<dc:creator>Joan Castell</dc:creator>
		<dc:creator>Zerlina Muir</dc:creator>
		<dc:creator>Jose Adzet</dc:creator>
		<dc:creator>Rosa Sabe</dc:creator>
		<dc:creator>Suzanne Schreyer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/608">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 608-621: Emerging Roles for Non-Coding RNAs in Male Reproductive Development in Flowering Plants]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/608</link>
	<description>Knowledge of sexual reproduction systems in flowering plants is essential to humankind, with crop fertility vitally important for food security. Here, we review rapidly emerging new evidence for the key importance of non-coding RNAs in male reproductive development in flowering plants. From the commitment of somatic cells to initiating reproductive development through to meiosis and the development of pollen—containing the male gametes (sperm cells)—in the anther, there is now overwhelming data for a diversity of non-coding RNAs and emerging evidence for crucial roles for them in regulating cellular events at these developmental stages. A particularly exciting development has been the association of one example of cytoplasmic male sterility, which has become an unparalleled breeding tool for producing new crop hybrids, with a non-coding RNA locus.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-12-04</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040608</prism:doi>
	<prism:startingPage>608</prism:startingPage>
		<prism:endingPage>621</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Emerging Roles for Non-Coding RNAs in Male Reproductive Development in Flowering Plants]]></dc:title>
    <dc:date>2012-12-04</dc:date>
	<dc:identifier>doi: 10.3390/biom2040608</dc:identifier>
    	<dc:creator>Robert Grant-Downton</dc:creator>
		<dc:creator>Josefina Rodriguez-Enriquez</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/579">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 579-607: Pathways for Genome Integrity in G2 Phase of the Cell Cycle]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/579</link>
	<description>The maintenance of genome integrity is important for normal cellular functions, organism development and the prevention of diseases, such as cancer. Cellular pathways respond immediately to DNA breaks leading to the initiation of a multi-facetted DNA damage response, which leads to DNA repair and cell cycle arrest. Cell cycle checkpoints provide the cell time to complete replication and repair the DNA damage before it can continue to the next cell cycle phase. The G2/M checkpoint plays an especially important role in ensuring the propagation of error-free copies of the genome to each daughter cell. Here, we review recent progress in our understanding of DNA repair and checkpoint pathways in late S and G2 phases. This review will first describe the current understanding of normal cell cycle progression through G2 phase to mitosis. It will also discuss the DNA damage response including cell cycle checkpoint control and DNA double-strand break repair. Finally, we discuss the emerging concept that DNA repair pathways play a major role in the G2/M checkpoint pathway thereby blocking cell division as long as DNA lesions are present.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-11-30</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040579</prism:doi>
	<prism:startingPage>579</prism:startingPage>
		<prism:endingPage>607</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Pathways for Genome Integrity in G2 Phase of the Cell Cycle]]></dc:title>
    <dc:date>2012-11-30</dc:date>
	<dc:identifier>doi: 10.3390/biom2040579</dc:identifier>
    	<dc:creator>Arne Kousholt</dc:creator>
		<dc:creator>Tobias Menzel</dc:creator>
		<dc:creator>Claus Sørensen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/564">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 564-578: Human DNA Glycosylase NEIL1’s Interactions with Downstream Repair Proteins Is Critical for Efficient Repair of Oxidized DNA Base Damage and Enhanced Cell Survival]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/564</link>
	<description>NEIL1 is unique among the oxidatively damaged base repair-initiating DNA glycosylases in the human genome due to its S phase-specific activation and ability to excise substrate base lesions from single-stranded DNA. We recently characterized NEIL1’s specific binding to downstream canonical repair and non-canonical accessory proteins, all of which involve NEIL1’s disordered C-terminal segment as the common interaction domain (CID). This domain is dispensable for NEIL1’s base excision and abasic (AP) lyase activities, but is required for its interactions with other repair proteins. Here, we show that truncated NEIL1 lacking the CID is markedly deficient in initiating in vitro repair of 5-hydroxyuracil (an oxidative deamination product of C) in a plasmid substrate compared to the wild-type NEIL1, thus suggesting a critical role of CID in the coordination of overall repair. Furthermore, while NEIL1 downregulation significantly sensitized human embryonic kidney (HEK) 293 cells to reactive oxygen species (ROS), ectopic wild-type NEIL1, but not the truncated mutant, restored resistance to ROS. These results demonstrate that cell survival and NEIL1-dependent repair of oxidative DNA base damage require interactions among repair proteins, which could be explored as a cancer therapeutic target in order to increase the efficiency of chemo/radiation treatment.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-11-15</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2040564</prism:doi>
	<prism:startingPage>564</prism:startingPage>
		<prism:endingPage>578</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Human DNA Glycosylase NEIL1’s Interactions with Downstream Repair Proteins Is Critical for Efficient Repair of Oxidized DNA Base Damage and Enhanced Cell Survival]]></dc:title>
    <dc:date>2012-11-15</dc:date>
	<dc:identifier>doi: 10.3390/biom2040564</dc:identifier>
    	<dc:creator>Muralidhar Hegde</dc:creator>
		<dc:creator>Pavana Hegde</dc:creator>
		<dc:creator>Dutta Arijit</dc:creator>
		<dc:creator>Istvan Boldogh</dc:creator>
		<dc:creator>Sankar Mitra</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/549">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 549-563: Hyaluronidases Have Strong Hydrolytic Activity toward Chondroitin 4-Sulfate Comparable to that for Hyaluronan]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/549</link>
	<description>Chondroitin sulfate (CS) chains are involved in the regulation of various biological processes. However, the mechanism underlying the catabolism of CS is not well understood. Hyaluronan (HA)-degrading enzymes, the hyaluronidases, are assumed to act at the initial stage of the degradation process, because HA is similar in structure to nonsulfated CS, chondroitin (Chn). Although human hyaluronidase-1 (HYAL1) and testicular hyaluronidase (SPAM1) can degrade not only HA but also CS, they are assumed to digest CS to only a limited extent. In this study, the hydrolytic activities of HYAL1 and SPAM1 toward CS-A, CS-C, Chn, and HA were compared. HYAL1 depolymerized CS-A and HA to a similar extent. SPAM1 degraded CS-A, Chn, and HA to a similar extent. CS is widely distributed from very primitive organisms to humans, whereas HA has been reported to be present only in vertebrates with the single exception of a mollusk. Therefore, a genuine substrate of hyaluronidases appears to be CS as well as HA.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-11-12</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2040549</prism:doi>
	<prism:startingPage>549</prism:startingPage>
		<prism:endingPage>563</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Hyaluronidases Have Strong Hydrolytic Activity toward Chondroitin 4-Sulfate Comparable to that for Hyaluronan]]></dc:title>
    <dc:date>2012-11-12</dc:date>
	<dc:identifier>doi: 10.3390/biom2040549</dc:identifier>
    	<dc:creator>Tomoko Honda</dc:creator>
		<dc:creator>Tomoyuki Kaneiwa</dc:creator>
		<dc:creator>Shuji Mizumoto</dc:creator>
		<dc:creator>Kazuyuki Sugahara</dc:creator>
		<dc:creator>Shuhei Yamada</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/524">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 524-548: Functional Aspects of PARP1 in DNA Repair and Transcription]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/524</link>
	<description>Poly (ADP-ribose) polymerase 1 (PARP1) is an ADP-ribosylating enzyme essential for initiating various forms of DNA repair. Inhibiting its enzyme activity with small molecules thus achieves synthetic lethality by preventing unwanted DNA repair in the treatment of cancers. Through enzyme-dependent chromatin remodeling and enzyme-independent motif recognition, PARP1 also plays important roles in regulating gene expression. Besides presenting current findings on how each process is individually controlled by PARP1, we shall discuss how transcription and DNA repair are so intricately linked that disturbance by PARP1 enzymatic inhibition, enzyme hyperactivation in diseases, and viral replication can favor one function while suppressing the other.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-11-12</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040524</prism:doi>
	<prism:startingPage>524</prism:startingPage>
		<prism:endingPage>548</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Functional Aspects of PARP1 in DNA Repair and Transcription]]></dc:title>
    <dc:date>2012-11-12</dc:date>
	<dc:identifier>doi: 10.3390/biom2040524</dc:identifier>
    	<dc:creator>Hui Ling Ko</dc:creator>
		<dc:creator>Ee Chee Ren</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/505">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 505-523: Preserving Yeast Genetic Heritage through DNA Damage Checkpoint Regulation and Telomere Maintenance]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/505</link>
	<description>In order to preserve genome integrity, extrinsic or intrinsic DNA damages must be repaired before they accumulate in cells and trigger other mutations and genome rearrangements. Eukaryotic cells are able to respond to different genotoxic stresses as well as to single DNA double strand breaks (DSBs), suggesting highly sensitive and robust mechanisms to detect lesions that trigger a signal transduction cascade which, in turn, controls the DNA damage response (DDR). Furthermore, cells must be able to distinguish natural chromosomal ends from DNA DSBs in order to prevent inappropriate checkpoint activation, DDR and chromosomal rearrangements. Since the original discovery of RAD9, the first DNA damage checkpoint gene identified in Saccharomyces cerevisiae, many genes that have a role in this pathway have been identified, including MRC1, MEC3, RAD24, RAD53, DUN1, MEC1 and TEL1. Extensive studies have established most of the genetic basis of the DNA damage checkpoint and uncovered its different functions in cell cycle regulation, DNA replication and repair, and telomere maintenance. However, major questions concerning the regulation and functions of the DNA damage checkpoint remain to be answered. First, how is the checkpoint activity coupled to DNA replication and repair? Second, how do cells distinguish natural chromosome ends from deleterious DNA DSBs? In this review we will examine primarily studies performed using Saccharomyces cerevisiae as a model system.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-10-30</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040505</prism:doi>
	<prism:startingPage>505</prism:startingPage>
		<prism:endingPage>523</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Preserving Yeast Genetic Heritage through DNA Damage Checkpoint Regulation and Telomere Maintenance]]></dc:title>
    <dc:date>2012-10-30</dc:date>
	<dc:identifier>doi: 10.3390/biom2040505</dc:identifier>
    	<dc:creator>Veronica Baldo</dc:creator>
		<dc:creator>Jason Liang</dc:creator>
		<dc:creator>Guoliang Wang</dc:creator>
		<dc:creator>Huilin Zhou</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/483">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 483-504: Break-Induced Replication and Genome Stability]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/483</link>
	<description>Genetic instabilities, including mutations and chromosomal rearrangements, lead to cancer and other diseases in humans and play an important role in evolution. A frequent cause of genetic instabilities is double-strand DNA breaks (DSBs), which may arise from a wide range of exogeneous and endogeneous cellular factors. Although the repair of DSBs is required, some repair pathways are dangerous because they may destabilize the genome. One such pathway, break-induced replication (BIR), is the mechanism for repairing DSBs that possesses only one repairable end. This situation commonly arises as a result of eroded telomeres or collapsed replication forks. Although BIR plays a positive role in repairing DSBs, it can alternatively be a dangerous source of several types of genetic instabilities, including loss of heterozygosity, telomere maintenance in the absence of telomerase, and non-reciprocal translocations. Also, mutation rates in BIR are about 1000 times higher as compared to normal DNA replication. In addition, micro-homology-mediated BIR (MMBIR), which is a mechanism related to BIR, can generate copy-number variations (CNVs) as well as various complex chromosomal rearrangements. Overall, activation of BIR may contribute to genomic destabilization resulting in substantial biological consequences including those affecting human health.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-10-16</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040483</prism:doi>
	<prism:startingPage>483</prism:startingPage>
		<prism:endingPage>504</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Break-Induced Replication and Genome Stability]]></dc:title>
    <dc:date>2012-10-16</dc:date>
	<dc:identifier>doi: 10.3390/biom2040483</dc:identifier>
    	<dc:creator>Cynthia Sakofsky</dc:creator>
		<dc:creator>Sandeep Ayyar</dc:creator>
		<dc:creator>Anna Malkova</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/467">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 467-482: Glycobiology Aspects of the Periodontal Pathogen Tannerella forsythia]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/467</link>
	<description>Glycobiology is important for the periodontal pathogen Tannerella forsythia, affecting the bacterium’s cellular integrity, its life-style, and virulence potential. The bacterium possesses a unique Gram-negative cell envelope with a glycosylated surface (S-) layer as outermost decoration that is proposed to be anchored via a rough lipopolysaccharide. The S-layer glycan has the structure 4‑MeO-b-ManpNAcCONH2-(1→3)-[Pse5Am7Gc-(2→4)-]-b-ManpNAcA-(1→4)-[4-MeO-a-Galp-(1→2)-]-a-Fucp-(1→4)-[-a-Xylp-(1→3)-]-b-GlcpA-(1→3)-[-b-Digp-(1→2)-]-a-Galp and is linked to distinct serine and threonine residues within the D(S/T)(A/I/L/M/T/V) amino acid motif. Also several other Tannerella proteins are modified with the S‑layer oligosaccharide, indicating the presence of a general O‑glycosylation system. Protein O‑glycosylation impacts the life-style of T. forsythia since truncated S-layer glycans present in a defined mutant favor biofilm formation. While the S‑layer has also been shown to be a virulence factor and to delay the bacterium&#039;s recognition by the innate immune system of the host, the contribution of glycosylation to modulating host immunity is currently unraveling. Recently, it was shown that Tannerella surface glycosylation has a role in restraining the Th17-mediated neutrophil infiltration in the gingival tissues. Related to its asaccharolytic physiology, T. forsythia expresses a robust enzymatic repertoire, including several glycosidases, such as sialidases, which are linked to specific growth requirements and are involved in triggering host tissue destruction. This review compiles the current knowledge on the glycobiology of T. forsythia.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-10-12</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040467</prism:doi>
	<prism:startingPage>467</prism:startingPage>
		<prism:endingPage>482</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Glycobiology Aspects of the Periodontal Pathogen Tannerella forsythia]]></dc:title>
    <dc:date>2012-10-12</dc:date>
	<dc:identifier>doi: 10.3390/biom2040467</dc:identifier>
    	<dc:creator>Gerald Posch</dc:creator>
		<dc:creator>Gerhard Sekot</dc:creator>
		<dc:creator>Valentin Friedrich</dc:creator>
		<dc:creator>Zoë A. Megson</dc:creator>
		<dc:creator>Andrea Koerdt</dc:creator>
		<dc:creator>Paul Messner</dc:creator>
		<dc:creator>Christina Schäffer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/435">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 435-466: Sialyl-Tn in Cancer: (How) Did We Miss the Target?]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/435</link>
	<description>Sialyl-Tn antigen (STn) is a short O-glycan containing a sialic acid residue a2,6-linked to GalNAca-O-Ser/Thr. The biosynthesis of STn is mediated by a specific sialyltransferase termed ST6GalNAc I, which competes with O-glycans elongating glycosyltransferases and prevents cancer cells from exhibiting longer O-glycans. While weakly expressed by fetal and normal adult tissues, STn is expressed by more than 80% of human carcinomas and in all cases, STn detection is associated with adverse outcome and decreased overall survival for the patients. Because of its pan-carcinoma expression associated with an adverse outcome, an anti-cancer vaccine, named Theratope, has been designed towards the STn epitope. In spite of the great enthusiasm around this immunotherapy, Theratope failed on Phase III clinical trial. However, in lieu of missing this target, one should consider to revise the Theratope design and the actual facts. In this review, we highlight the many lessons that can be learned from this failure from the immunological standpoint, as well as from the drug design and formulation and patient selection. Moreover, an irrefutable knowledge is arising from novel immunotherapies targeting other carbohydrate antigens and STn carrier proteins, such as MUC1, that will warrantee the future development of more successful anti-STn immunotherapy strategies.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-10-11</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040435</prism:doi>
	<prism:startingPage>435</prism:startingPage>
		<prism:endingPage>466</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Sialyl-Tn in Cancer: (How) Did We Miss the Target?]]></dc:title>
    <dc:date>2012-10-11</dc:date>
	<dc:identifier>doi: 10.3390/biom2040435</dc:identifier>
    	<dc:creator>Sylvain Julien</dc:creator>
		<dc:creator>Paula A. Videira</dc:creator>
		<dc:creator>Philippe Delannoy</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/4/415">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 415-434: Promiscuity of the Euonymus Carbohydrate-Binding Domain]]></title>
	<link>http://www.mdpi.com/2218-273X/2/4/415</link>
	<description>Plants synthesize small amounts of carbohydrate-binding proteins on exposure to stress. For example, on exposure to drought, high salt, wounding and by treatment with some plant hormones or by pathogen attack. In contrast to the ‘classical’ plant lectins that are mostly located in the vacuolar compartment, this new class of inducible lectins is present in the cytoplasm and in the nucleus. Taking into account that any physiological role of plant lectins most likely relies on their specific carbohydrate-binding activity and specificity, the discovery of these stress-related lectins provides strong evidence for the importance of protein-carbohydrate-interactions in plant cells. Hitherto, six families of such nucleocytoplasmic lectins have been identified in plants. This review will focus on the nucleocytoplasmic lectins with one or more Euonymus lectin (EUL) domain(s). The carbohydrate-binding specificity of EUL proteins from a monocot, a dicot and a lower plant has been compared. Furthermore, modeling of the different EUL domains revealed a similar ß-trefoil fold consisting of three bundles of ß-sheet organized around a pseudo three-fold symmetry axis. Despite the sequence similarity and the conserved amino acids in the binding site, glycan array analyses showed that the EUL domain has a promiscuous carbohydrate-binding site capable of accommodating high mannose N-glycans, blood group B related structures and galactosylated epitopes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-10-08</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2040415</prism:doi>
	<prism:startingPage>415</prism:startingPage>
		<prism:endingPage>434</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Promiscuity of the Euonymus Carbohydrate-Binding Domain]]></dc:title>
    <dc:date>2012-10-08</dc:date>
	<dc:identifier>doi: 10.3390/biom2040415</dc:identifier>
    	<dc:creator>Elke Fouquaert</dc:creator>
		<dc:creator>Els J.M. Van Damme</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/3/389">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 389-414: Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)]]></title>
	<link>http://www.mdpi.com/2218-273X/2/3/389</link>
	<description>Platelet glycoprotein 4 (CD36) (or fatty acyl translocase [FAT], or scavenger receptor class B, member 3 [SCARB3]) is an essential cell surface and skeletal muscle outer mitochondrial membrane glycoprotein involved in multiple functions in the body. CD36 serves as a ligand receptor of thrombospondin, long chain fatty acids, oxidized low density lipoproteins (LDLs) and malaria-infected erythrocytes. CD36 also influences various diseases, including angiogenesis, thrombosis, atherosclerosis, malaria, diabetes, steatosis, dementia and obesity. Genetic deficiency of this protein results in significant changes in fatty acid and oxidized lipid uptake. Comparative CD36 amino acid sequences and structures and CD36 gene locations were examined using data from several vertebrate genome projects. Vertebrate CD36 sequences shared 53–100% identity as compared with 29–32% sequence identities with other CD36-like superfamily members, SCARB1 and SCARB2. At least eight vertebrate CD36 N-glycosylation sites were conserved which are required for membrane integration. Sequence alignments, key amino acid residues and predicted secondary structures were also studied. Three CD36 domains were identified including cytoplasmic, transmembrane and exoplasmic sequences. Conserved sequences included N- and C-terminal transmembrane glycines; and exoplasmic cysteine disulphide residues; TSP-1 and PE binding sites, Thr92 and His242, respectively; 17 conserved proline and 14 glycine residues, which may participate in forming CD36 ‘short loops’; and basic amino acid residues, and may contribute to fatty acid and thrombospondin binding. Vertebrate CD36 genes usually contained 12 coding exons. The human CD36 gene contained transcription factor binding sites (including PPARG and PPARA) contributing to a high gene expression level (6.6 times average). Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate CD36 gene with vertebrate SCARB1 and SCARB2 genes. These suggested that CD36 originated in an ancestral genome and was subsequently duplicated to form three vertebrate CD36 gene family members, SCARB1, SCARB2 and CD36.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-09-24</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2030389</prism:doi>
	<prism:startingPage>389</prism:startingPage>
		<prism:endingPage>414</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)]]></dc:title>
    <dc:date>2012-09-24</dc:date>
	<dc:identifier>doi: 10.3390/biom2030389</dc:identifier>
    	<dc:creator>Roger S. Holmes</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/3/376">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 376-388: Sumoylation and the DNA Damage Response]]></title>
	<link>http://www.mdpi.com/2218-273X/2/3/376</link>
	<description>The cellular response to DNA damage involves multiple pathways that work together to promote survival in the face of increased genotoxic lesions. Proteins in these pathways are often posttranslationally modified, either by small groups such as phosphate, or by protein modifiers such as ubiquitin or SUMO. The recent discovery of many more SUMO substrates that are modified at higher levels in damage conditions adds weight to the accumulated evidence suggesting that sumoylation plays an important functional role in the DNA damage response. Here we discuss the significance of DNA damage-induced sumoylation, the effects of sumoylation on repair proteins, sumoylation dynamics, and crosstalk with other posttranslational modifications in the DNA damage response.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-09-04</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2030376</prism:doi>
	<prism:startingPage>376</prism:startingPage>
		<prism:endingPage>388</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Sumoylation and the DNA Damage Response]]></dc:title>
    <dc:date>2012-09-04</dc:date>
	<dc:identifier>doi: 10.3390/biom2030376</dc:identifier>
    	<dc:creator>Catherine A. Cremona</dc:creator>
		<dc:creator>Prabha Sarangi</dc:creator>
		<dc:creator>Xiaolan Zhao</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/3/350">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 350-375: SUMO Wrestles with Recombination]]></title>
	<link>http://www.mdpi.com/2218-273X/2/3/350</link>
	<description>DNA double-strand breaks (DSBs) comprise one of the most toxic DNA lesions, as the failure to repair a single DSB has detrimental consequences on the cell. Homologous recombination (HR) constitutes an error-free repair pathway for the repair of DSBs. On the other hand, when uncontrolled, HR can lead to genome rearrangements and needs to be tightly regulated. In recent years, several proteins involved in different steps of HR have been shown to undergo modification by small ubiquitin-like modifier (SUMO) peptide and it has been suggested that deficient sumoylation impairs the progression of HR. This review addresses specific effects of sumoylation on the properties of various HR proteins and describes its importance for the homeostasis of DNA repetitive sequences. The article further illustrates the role of sumoylation in meiotic recombination and the interplay between SUMO and other post-translational modifications.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-07-25</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2030350</prism:doi>
	<prism:startingPage>350</prism:startingPage>
		<prism:endingPage>375</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[SUMO Wrestles with Recombination]]></dc:title>
    <dc:date>2012-07-25</dc:date>
	<dc:identifier>doi: 10.3390/biom2030350</dc:identifier>
    	<dc:creator>Veronika Altmannová</dc:creator>
		<dc:creator>Peter Kolesár</dc:creator>
		<dc:creator>Lumír Krejčí</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/3/331">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 331-349: SUMOylation in Drosophila Development]]></title>
	<link>http://www.mdpi.com/2218-273X/2/3/331</link>
	<description>Small ubiquitin-related modifier (SUMO), an ~90 amino acid ubiquitin-like protein, is highly conserved throughout the eukaryotic domain. Like ubiquitin, SUMO is covalently attached to lysine side chains in a large number of target proteins. In contrast to ubiquitin, SUMO does not have a direct role in targeting proteins for proteasomal degradation. However, like ubiquitin, SUMO does modulate protein function in a variety of other ways. This includes effects on protein conformation, subcellular localization, and protein–protein interactions. Significant insight into the in vivo role of SUMOylation has been provided by studies in Drosophila that combine genetic manipulation, proteomic, and biochemical analysis. Such studies have revealed that the SUMO conjugation pathway regulates a wide variety of critical cellular and developmental processes, including chromatin/chromosome function, eggshell patterning, embryonic pattern formation, metamorphosis, larval and pupal development, neurogenesis, development of the innate immune system, and apoptosis. This review discusses our current understanding of the diverse roles for SUMO in Drosophila development.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-07-25</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2030331</prism:doi>
	<prism:startingPage>331</prism:startingPage>
		<prism:endingPage>349</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[SUMOylation in Drosophila Development]]></dc:title>
    <dc:date>2012-07-25</dc:date>
	<dc:identifier>doi: 10.3390/biom2030331</dc:identifier>
    	<dc:creator>Matthew Smith</dc:creator>
		<dc:creator>Wiam Turki-Judeh</dc:creator>
		<dc:creator>Albert J. Courey</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/3/312">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 312-330: SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes]]></title>
	<link>http://www.mdpi.com/2218-273X/2/3/312</link>
	<description>Post-translational modifications are able to regulate protein function and cellular processes in a rapid and reversible way. SUMOylation, the post-translational modification of proteins by the addition of SUMO, is a highly conserved process that seems to be present in modern cells. However, the mechanism of protein SUMOylation in earlier divergent eukaryotes, such as Giardia lamblia, is only starting to become apparent. In this work, we report the presence of a single SUMO gene encoding to SUMO protein in Giardia. Monoclonal antibodies against recombinant Giardia SUMO protein revealed the cytoplasmic localization of native SUMO in wild-type trophozoites. Moreover, the over-expression of SUMO protein showed a mainly cytoplasmic localization, though also neighboring the plasma membrane, flagella, and around and even inside the nuclei. Western blot assays revealed a number of SUMOylated proteins in a range between 20 and 120 kDa. The genes corresponding to putative enzymes involved in the SUMOylation pathway were also explored. Our results as a whole suggest that SUMOylation is a process conserved in the eukaryotic lineage, and that its study is significant for understanding the biology of this interesting parasite and the role of post-translational modification in its evolution.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-07-25</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2030312</prism:doi>
	<prism:startingPage>312</prism:startingPage>
		<prism:endingPage>330</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes]]></dc:title>
    <dc:date>2012-07-25</dc:date>
	<dc:identifier>doi: 10.3390/biom2030312</dc:identifier>
    	<dc:creator>Cecilia V. Vranych</dc:creator>
		<dc:creator>María C. Merino</dc:creator>
		<dc:creator>Nahuel Zamponi</dc:creator>
		<dc:creator>María C. Touz</dc:creator>
		<dc:creator>Andrea S. Rópolo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/288">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 288-311: Leucine-Rich Repeat (LRR) Domains Containing Intervening Motifs in Plants]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/288</link>
	<description>LRRs (leucine rich repeats) are present in over 14,000 proteins. Non-LRR, island regions (IRs) interrupting LRRs are widely distributed. The present article reviews 19 families of LRR proteins having non-LRR IRs (LRR@IR proteins) from various plant species. The LRR@IR proteins are LRR-containing receptor-like kinases (LRR-RLKs), LRR-containing receptor-like proteins (LRR-RLPs), TONSOKU/BRUSHY1, and MJK13.7; the LRR-RLKs are homologs of TMK1/Rhg4, BRI1, PSKR, PSYR1, Arabidopsis At1g74360, and RPK2, while the LRR-RLPs are those of Cf-9/Cf-4, Cf-2/Cf-5, Ve, HcrVf, RPP27, EIX1, clavata 2, fascinated ear2, RLP2, rice Os10g0479700, and putative soybean disease resistance protein. The LRRs are intersected by single, non-LRR IRs; only the RPK2 homologs have two IRs. In most of the LRR-RLKs and LRR-RLPs, the number of repeat units in the preceding LRR block (N1) is greater than the number of the following block (N2); N1 » N2 in which N1 is variable in the homologs of individual families, while N2 is highly conserved. The five families of the LRR-RLKs except for the RPK2 family show N1 = 8 − 18 and N2 = 3 − 5. The nine families of the LRR-RLPs show N1 = 12 − 33 and N2 = 4; while N1 = 6 and N2 = 4 for the rice Os10g0479700 family and the N1 = 4 − 28 and N2 = 4 for the soybean protein family. The rule of N1 » N2 might play a common, significant role in ligand interaction, dimerization, and/or signal transduction of the LRR-RLKs and the LRR-RLPs. The structure and evolution of the LRR domains with non-LRR IRs and their proteins are also discussed.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-06-22</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2020288</prism:doi>
	<prism:startingPage>288</prism:startingPage>
		<prism:endingPage>311</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Leucine-Rich Repeat (LRR) Domains Containing Intervening Motifs in Plants]]></dc:title>
    <dc:date>2012-06-22</dc:date>
	<dc:identifier>doi: 10.3390/biom2020288</dc:identifier>
    	<dc:creator>Norio Matsushima</dc:creator>
		<dc:creator>Hiroki Miyashita</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/282">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 282-287: From Phosphorous to Arsenic: Changing the Classic Paradigm for the Structure of Biomolecules]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/282</link>
	<description>Biomolecules are composed primarily of the elements carbon, nitrogen, hydrogen, oxygen, sulfur, and phosphorus. The structured assembly of these elements forms the basis for proteins, nucleic acids and lipids. However, the recent discovery of a new bacterium, strain GFAJ-1 of the Halomonadaceae, has shaken the classic paradigms for the architecture of life. Mounting evidence supports the claim that these bacteria substitute arsenic for phosphorus in macromolecules. Herein, we provide a brief commentary and fuel the debate related to what may be a most unusual organism.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-05-30</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Commentary</prism:section>
	<prism:doi>10.3390/biom2020282</prism:doi>
	<prism:startingPage>282</prism:startingPage>
		<prism:endingPage>287</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[From Phosphorous to Arsenic: Changing the Classic Paradigm for the Structure of Biomolecules]]></dc:title>
    <dc:date>2012-05-30</dc:date>
	<dc:identifier>doi: 10.3390/biom2020282</dc:identifier>
    	<dc:creator>Ryan Knodle</dc:creator>
		<dc:creator>Pratima Agarwal</dc:creator>
		<dc:creator>Mark Brown</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/269">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 269-281: DeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/269</link>
	<description>The secretion of insulin by pancreatic islet β-cells plays a pivotal role in glucose homeostasis and diabetes. Recent work suggests an important role for SUMOylation in the control of insulin secretion from β-cells. In this paper we discuss mechanisms whereby (de)SUMOylation may control insulin release by modulating β-cell function at one or more key points; and particularly through the acute and reversible regulation of the exocytotic machinery. Furthermore, we postulate that the SUMO-specific protease SENP1 is an important mediator of insulin exocytosis in response to NADPH, a metabolic secretory signal and major determinant of β-cell redox state. Dialysis of mouse β-cells with NADPH efficiently amplifies β-cell exocytosis even when extracellular glucose is low; an effect that is lost upon knockdown of SENP1. Conversely, over-expression of SENP1 itself augments β-cell exocytosis in a redox-dependent manner. Taken together, we suggest that (de)SUMOylation represents an important mechanism that acutely regulates insulin secretion and that SENP1 can act as an amplifier of insulin exocytosis.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-05-24</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2020269</prism:doi>
	<prism:startingPage>269</prism:startingPage>
		<prism:endingPage>281</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[DeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals]]></dc:title>
    <dc:date>2012-05-24</dc:date>
	<dc:identifier>doi: 10.3390/biom2020269</dc:identifier>
    	<dc:creator>Elisa Vergari</dc:creator>
		<dc:creator>Gregory Plummer</dc:creator>
		<dc:creator>Xiaoqing Dai</dc:creator>
		<dc:creator>Patrick E. MacDonald</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/256">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 256-268: Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/256</link>
	<description>Post-translational modifications of proteins are essential for cell function. Covalent modification by SUMO (small ubiquitin-like modifier) plays a role in multiple cell processes, including transcriptional regulation, DNA damage repair, protein localization and trafficking. Factors affecting protein localization and trafficking are particularly crucial in neurons because of their polarization, morphological complexity and functional specialization. SUMOylation has emerged as a major mediator of intranuclear and nucleo-cytoplasmic translocations of proteins involved in critical pathways such as circadian rhythm, apoptosis and protein degradation. In addition, SUMO-regulated re-localization of extranuclear proteins is required to sustain neuronal excitability and synaptic transmission. Thus, SUMOylation is a key arbiter of neuronal viability and function. Here, we provide an overview of recent advances in our understanding of regulation of neuronal protein localization and translocation by SUMO and highlight exciting areas of ongoing research.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-05-14</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2020256</prism:doi>
	<prism:startingPage>256</prism:startingPage>
		<prism:endingPage>268</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation]]></dc:title>
    <dc:date>2012-05-14</dc:date>
	<dc:identifier>doi: 10.3390/biom2020256</dc:identifier>
    	<dc:creator>Anja Berndt</dc:creator>
		<dc:creator>Kevin A. Wilkinson</dc:creator>
		<dc:creator>Jeremy M. Henley</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/240">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 240-255: The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/240</link>
	<description>SUMO (small ubiquitin-related modifier) conjugation is a reversible three-step process of protein post-translational modifications mediating protein-protein interactions, subcellular compartmentalization and regulation of transcriptional events. Among divergent transcription factors regulated by SUMOylation and deSUMOylation, the androgen receptor (AR) is of exceptional significance, given its established role in prostate carcinogenesis. The enzymes of the SUMO pathway can have diverse effects on AR transcriptional activity, either via direct modification of the AR or through modification of AR co-regulators. Accumulating in vitro and in vivo evidence implicates the SUMO pathway in AR-dependent signaling. Prostate cancer cell proliferation and hypoxia-induced angiogenesis are also regulated by the SUMO pathway, through an AR-independent mechanism. Thus, an important role has been revealed for members of the SUMO pathway in prostate cancer (PCa) development and progression, offering new therapeutic targets.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-04-23</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2020240</prism:doi>
	<prism:startingPage>240</prism:startingPage>
		<prism:endingPage>255</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer]]></dc:title>
    <dc:date>2012-04-23</dc:date>
	<dc:identifier>doi: 10.3390/biom2020240</dc:identifier>
    	<dc:creator>Panagiotis J. Vlachostergios</dc:creator>
		<dc:creator>Christos N. Papandreou</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/228">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 228-239: Genetic Fingerprinting of Wheat and Its Progenitors by Mitochondrial Gene orf256]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/228</link>
	<description>orf256 is a wheat mitochondrial gene associated with cytoplasmic male sterility (CMS) that has different organization in various species. This study exploited the orf256 gene as a mitochondrial DNA marker to study the genetic fingerprint of Triticum and Aegilops species. PCR followed by sequencing of common parts of the orf256 gene were employed to determine the fingerprint and molecular evolution of Triticum and Aegilops species. Although many primer pairs were used, two pairs of orf256 specific primers (5:-94/C: 482, 5:253/C: 482), amplified DNA fragments of 576 bp and 230 bp respectively in all species were tested. A common 500 bp of nine species of Triticum and Aegilops were aligned and showed consistent results with that obtained from other similar chloroplast or nuclear genes. Base alignment showed that there were various numbers of base substitutions in all species compared to S. cereal (Sc) (the outgroup species). Phylogenetic relationship revealed similar locations and proximity on phylogenetic trees established using plastid and nuclear genes. The results of this study open a good route to use unknown function genes of mitochondria in studying the molecular relationships and evolution of wheat and complex plant genomes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-04-13</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2020228</prism:doi>
	<prism:startingPage>228</prism:startingPage>
		<prism:endingPage>239</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Genetic Fingerprinting of Wheat and Its Progenitors by Mitochondrial Gene orf256]]></dc:title>
    <dc:date>2012-04-13</dc:date>
	<dc:identifier>doi: 10.3390/biom2020228</dc:identifier>
    	<dc:creator>Ahmed M. El-Shehawi</dc:creator>
		<dc:creator>Abdelmeguid I. Fahmi</dc:creator>
		<dc:creator>Samy M. Sayed</dc:creator>
		<dc:creator>Mona M. Elseehy</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/203">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 203-227: Sumoylation at the Host-Pathogen Interface]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/203</link>
	<description>Many viral proteins have been shown to be sumoylated with corresponding regulatory effects on their protein function, indicating that this host cell modification process is widely exploited by viral pathogens to control viral activity. In addition to using sumoylation to regulate their own proteins, several viral pathogens have been shown to modulate overall host sumoylation levels. Given the large number of cellular targets for SUMO addition and the breadth of critical cellular processes that are regulated via sumoylation, viral modulation of overall sumoylation presumably alters the cellular environment to ensure that it is favorable for viral reproduction and/or persistence. Like some viruses, certain bacterial plant pathogens also target the sumoylation system, usually decreasing sumoylation to disrupt host anti-pathogen responses. The recent demonstration that Listeria monocytogenes also disrupts host sumoylation, and that this is required for efficient infection, extends the plant pathogen observations to a human pathogen and suggests that pathogen modulation of host sumoylation may be more widespread than previously appreciated. This review will focus on recent aspects of how pathogens modulate the host sumoylation system and how this benefits the pathogen.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-04-05</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2020203</prism:doi>
	<prism:startingPage>203</prism:startingPage>
		<prism:endingPage>227</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Sumoylation at the Host-Pathogen Interface]]></dc:title>
    <dc:date>2012-04-05</dc:date>
	<dc:identifier>doi: 10.3390/biom2020203</dc:identifier>
    	<dc:creator>Van G. Wilson</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/2/187">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 187-202: Cell Penetrating Peptides in the Delivery of Biopharmaceuticals]]></title>
	<link>http://www.mdpi.com/2218-273X/2/2/187</link>
	<description>The cell membrane is a highly selective barrier. This limits the cellular uptake of molecules including DNA, oligonucleotides, peptides and proteins used as therapeutic agents. Different approaches have been employed to increase the membrane permeability and intracellular delivery of these therapeutic molecules. One such approach is the use of Cell Penetrating Peptides (CPPs). CPPs represent a new and innovative concept, which bypasses the problem of bioavailability of drugs. The success of CPPs lies in their ability to unlock intracellular and even intranuclear targets for the delivery of agents ranging from peptides to antibodies and drug-loaded nanoparticles. This review highlights the development of cell penetrating peptides for cell-specific delivery strategies involving biomolecules that can be triggered spatially and temporally within a cell transport pathway by change in physiological conditions. The review also discusses conjugations of therapeutic agents to CPPs for enhanced intracellular delivery and bioavailability that are at the clinical stage of development.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-03-30</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2020187</prism:doi>
	<prism:startingPage>187</prism:startingPage>
		<prism:endingPage>202</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Cell Penetrating Peptides in the Delivery of Biopharmaceuticals]]></dc:title>
    <dc:date>2012-03-30</dc:date>
	<dc:identifier>doi: 10.3390/biom2020187</dc:identifier>
    	<dc:creator>Were LL Munyendo</dc:creator>
		<dc:creator>Huixia Lv</dc:creator>
		<dc:creator>Habiba Benza-Ingoula</dc:creator>
		<dc:creator>Lilechi D. Baraza</dc:creator>
		<dc:creator>Jianping Zhou</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/165">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 165-186: Endoplasmic Reticulum Calcium Pumps and Cancer Cell Differentiation]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/165</link>
	<description>The endoplasmic reticulum (ER) is a major intracellular calcium storage pool and a multifunctional organelle that accomplishes several calcium-dependent functions involved in many homeostatic and signaling mechanisms. Calcium is accumulated in the ER by Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA)-type calcium pumps. SERCA activity can determine ER calcium content available for intra-ER functions and for calcium release into the cytosol, and can shape the spatiotemporal characteristics of calcium signals. SERCA function therefore constitutes an important nodal point in the regulation of cellular calcium homeostasis and signaling, and can exert important effects on cell growth, differentiation and survival. In several cell types such as cells of hematopoietic origin, mammary, gastric and colonic epithelium, SERCA2 and SERCA3-type calcium pumps are simultaneously expressed, and SERCA3 expression levels undergo significant changes during cell differentiation, activation or immortalization. In addition, SERCA3 expression is decreased or lost in several tumor types when compared to the corresponding normal tissue. These observations indicate that ER calcium homeostasis is remodeled during cell differentiation, and may present defects due to decreased SERCA3 expression in tumors. Modulation of the state of differentiation of the ER reflected by SERCA3 expression constitutes an interesting new aspect of cell differentiation and tumor biology.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-03-05</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2010165</prism:doi>
	<prism:startingPage>165</prism:startingPage>
		<prism:endingPage>186</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Endoplasmic Reticulum Calcium Pumps and Cancer Cell Differentiation]]></dc:title>
    <dc:date>2012-03-05</dc:date>
	<dc:identifier>doi: 10.3390/biom2010165</dc:identifier>
    	<dc:creator>Béla Papp</dc:creator>
		<dc:creator>Jean-Philippe Brouland</dc:creator>
		<dc:creator>Atousa Arbabian</dc:creator>
		<dc:creator>Pascal Gélébart</dc:creator>
		<dc:creator>Tünde Kovács</dc:creator>
		<dc:creator>Régis Bobe</dc:creator>
		<dc:creator>Jocelyne Enouf</dc:creator>
		<dc:creator>Nadine Varin-Blank</dc:creator>
		<dc:creator>Ágota Apáti</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/143">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 143-164: Mortalin, Apoptosis, and Neurodegeneration]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/143</link>
	<description>Mortalin is a highly conserved heat-shock chaperone usually found in multiple subcellular locations. It has several binding partners and has been implicated in various functions ranging from stress response, control of cell proliferation, and inhibition/prevention of apoptosis. The activity of this protein involves different structural and functional mechanisms, and minor alterations in its expression level may lead to serious biological consequences, including neurodegeneration. In this article we review the most current data associated with mortalin’s binding partners and how these protein-protein interactions may be implicated in apoptosis and neurodegeneration. A complete understanding of the molecular pathways in which mortalin is involved is important for the development of therapeutic strategies for cancer and neurodegenerative diseases.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-03-01</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2010143</prism:doi>
	<prism:startingPage>143</prism:startingPage>
		<prism:endingPage>164</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Mortalin, Apoptosis, and Neurodegeneration]]></dc:title>
    <dc:date>2012-03-01</dc:date>
	<dc:identifier>doi: 10.3390/biom2010143</dc:identifier>
    	<dc:creator>Carolina Londono</dc:creator>
		<dc:creator>Cristina Osorio</dc:creator>
		<dc:creator>Vivian Gama</dc:creator>
		<dc:creator>Oscar Alzate</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/122">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 122-142: Interaction of PTPIP51 with Tubulin, CGI-99 and Nuf2 During Cell Cycle Progression]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/122</link>
	<description>Protein tyrosine phosphatase interacting protein 51 (PTPIP51), also known as regulator of microtubule dynamics protein 3, was identified as an in vitro and in vivo interaction partner of CGI-99 and Nuf-2. PTPIP51 mRNA is expressed in all stages of the cell cycle; it is highly expressed six hours post-nocodazole treatment and minimally expressed one hour post-nocodazole treatment. Recent investigations located PTPIP51 protein at the equatorial plate. This study reports the localization of the PTPIP51/CGI-99 and the PTPIP51/Nuf-2 complex at the equatorial region during mitosis. Moreover, Duolink proximity ligation assays revealed an association of PTPIP51 with the microtubular cytoskeleton and the spindle apparatus. High amounts of phosphorylated PTPIP51 associated with the spindle poles was seen by confocal microscopy. In parallel a strong interaction of PTPIP51 with the epidermal growth factor receptor phosphorylating PTPIP51 at the tyrosine 176 residue was seen. In the M/G1 transition a high level of interaction between PTPIP51 and PTP1B was registered, thus restoring the interaction of PTPIP51 and Raf-1, depleted in mitotic cells. Summarizing these new facts, we conclude that PTPIP51 is necessary for normal mitotic processes, impacting on chromosomal division and control of the MAPK pathway activity.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-02-23</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2010122</prism:doi>
	<prism:startingPage>122</prism:startingPage>
		<prism:endingPage>142</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Interaction of PTPIP51 with Tubulin, CGI-99 and Nuf2 During Cell Cycle Progression]]></dc:title>
    <dc:date>2012-02-23</dc:date>
	<dc:identifier>doi: 10.3390/biom2010122</dc:identifier>
    	<dc:creator>Alexander Brobeil</dc:creator>
		<dc:creator>Michaela Graf</dc:creator>
		<dc:creator>Moritz Eiber</dc:creator>
		<dc:creator>Monika Wimmer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/104">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 104-121: Conformational Ensembles of an Intrinsically Disordered Protein pKID with and without a KIX Domain in Explicit Solvent Investigated by All-Atom Multicanonical Molecular Dynamics]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/104</link>
	<description>The phosphorylated kinase-inducible activation domain (pKID) adopts a helix–loop–helix structure upon binding to its partner KIX, although it is unstructured in the unbound state. The N-terminal and C-terminal regions of pKID, which adopt helices in the complex, are called, respectively, αA and αB. We performed all-atom multicanonical molecular dynamics simulations of pKID with and without KIX in explicit solvents to generate conformational ensembles. Although the unbound pKID was disordered overall, αA and αB exhibited a nascent helix propensity; the propensity of αA was stronger than that of αB, which agrees with experimental results. In the bound state, the free-energy landscape of αB involved two low free-energy fractions: native-like and non-native fractions. This result suggests that αB folds according to the induced-fit mechanism. The αB-helix direction was well aligned as in the NMR complex structure, although the αA helix exhibited high flexibility. These results also agree quantitatively with experimental observations. We have detected that the αB helix can bind to another site of KIX, to which another protein MLL also binds with the adopting helix. Consequently, MLL can facilitate pKID binding to the pKID-binding site by blocking the MLL-binding site. This also supports experimentally obtained results.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-02-22</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2010104</prism:doi>
	<prism:startingPage>104</prism:startingPage>
		<prism:endingPage>121</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Conformational Ensembles of an Intrinsically Disordered Protein pKID with and without a KIX Domain in Explicit Solvent Investigated by All-Atom Multicanonical Molecular Dynamics]]></dc:title>
    <dc:date>2012-02-22</dc:date>
	<dc:identifier>doi: 10.3390/biom2010104</dc:identifier>
    	<dc:creator>Koji Umezawa</dc:creator>
		<dc:creator>Jinzen Ikebe</dc:creator>
		<dc:creator>Mitsunori Takano</dc:creator>
		<dc:creator>Haruki Nakamura</dc:creator>
		<dc:creator>Junichi Higo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/76">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 76-103: Oxysterols and Their Cellular Effectors]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/76</link>
	<description>Oxysterols are oxidized 27-carbon cholesterol derivatives or by-products of cholesterol biosynthesis, with a spectrum of biologic activities. Several oxysterols have cytotoxic and pro-apoptotic activities, the ability to interfere with the lateral domain organization, and packing of membrane lipids. These properties may account for their suggested roles in the pathology of diseases such as atherosclerosis, age-onset macular degeneration and Alzheimer’s disease. Oxysterols also have the capacity to induce inflammatory responses and play roles in cell differentiation processes. The functions of oxysterols as intermediates in the synthesis of bile acids and steroid hormones, and as readily transportable forms of sterol, are well established. Furthermore, their actions as endogenous regulators of gene expression in lipid metabolism via liver X receptors and the Insig (insulin-induced gene) proteins have been investigated in detail. The cytoplasmic oxysterol-binding protein (OSBP) homologues form a group of oxysterol/cholesterol sensors that has recently attracted a lot of attention. However, their mode of action is, as yet, poorly understood. Retinoic acid receptor-related orphan receptors (ROR) α and γ, and Epstein-Barr virus induced gene 2 (EBI2) have been identified as novel oxysterol receptors, revealing new physiologic oxysterol effector mechanisms in development, metabolism, and immunity, and evoking enhanced interest in these compounds in the field of biomedicine.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-02-15</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2010076</prism:doi>
	<prism:startingPage>76</prism:startingPage>
		<prism:endingPage>103</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Oxysterols and Their Cellular Effectors]]></dc:title>
    <dc:date>2012-02-15</dc:date>
	<dc:identifier>doi: 10.3390/biom2010076</dc:identifier>
    	<dc:creator>Vesa M. Olkkonen</dc:creator>
		<dc:creator>Olivier Béaslas</dc:creator>
		<dc:creator>Eija Nissilä</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/46">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 46-75: Factor H: A Complement Regulator in Health and Disease, and a Mediator of Cellular Interactions]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/46</link>
	<description>Complement is an essential part of innate immunity as it participates in host defense against infections, disposal of cellular debris and apoptotic cells, inflammatory processes and modulation of adaptive immune responses. Several soluble and membrane-bound regulators protect the host from the potentially deleterious effects of uncontrolled and misdirected complement activation. Factor H is a major soluble regulator of the alternative complement pathway, but it can also bind to host cells and tissues, protecting them from complement attack. Interactions of factor H with various endogenous ligands, such as pentraxins, extracellular matrix proteins and DNA are important in limiting local complement-mediated inflammation. Impaired regulatory as well as ligand and cell recognition functions of factor H, caused by mutations or autoantibodies, are associated with the kidney diseases: atypical hemolytic uremic syndrome and dense deposit disease and the eye disorder: age-related macular degeneration. In addition, factor H binds to receptors on host cells and is involved in adhesion, phagocytosis and modulation of cell activation. In this review we discuss current concepts on the physiological and pathophysiological roles of factor H in light of new data and recent developments in our understanding of the versatile roles of factor H as an inhibitor of complement activation and inflammation, as well as a mediator of cellular interactions. A detailed knowledge of the functions of factor H in health and disease is expected to unravel novel therapeutic intervention possibilities and to facilitate the development or improvement of therapies.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-02-07</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2010046</prism:doi>
	<prism:startingPage>46</prism:startingPage>
		<prism:endingPage>75</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Factor H: A Complement Regulator in Health and Disease, and a Mediator of Cellular Interactions]]></dc:title>
    <dc:date>2012-02-07</dc:date>
	<dc:identifier>doi: 10.3390/biom2010046</dc:identifier>
    	<dc:creator>Anne Kopp</dc:creator>
		<dc:creator>Mario Hebecker</dc:creator>
		<dc:creator>Eliška Svobodová</dc:creator>
		<dc:creator>Mihály Józsi</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/34">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 34-45: Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/34</link>
	<description>Oligosaccharides, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules. Fucosylation is one of the most important oligosaccharide modifications involved in cancer and inflammation. Recent advances in glycomics have identified several types of glyco-biomarkers containing fucosylation that are linked to certain types of cancer. Fucosylated alpha-fetoprotein (AFP) is widely used in the diagnosis of hepatocellular carcinoma because it is more specific than alpha-fetoprotein. High levels of fucosylated haptoglobin have also been found in sera of patients with various carcinomas. We have recently established a simple lectin-antibody ELISA to measure fucosylated haptoglobin and to investigate its clinical use. Cellular fucosylation is dependent upon fucosyltransferase activity and the level of its donor substrate, guanosine diphosphate (GDP)-fucose. GDP-mannose-4,6-dehydratase (GMDS) is a key enzyme involved in the synthesis of GDP-fucose. Mutations of GMDS found in colon cancer cells induced a malignant phenotype, leading to rapid growth in athymic mice resistant to natural killer cells. This review describes the role of fucosylated haptoglobin as a cancer biomarker, and discusses the possible biological role of fucosylation in cancer development.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-01-30</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom2010034</prism:doi>
	<prism:startingPage>34</prism:startingPage>
		<prism:endingPage>45</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy]]></dc:title>
    <dc:date>2012-01-30</dc:date>
	<dc:identifier>doi: 10.3390/biom2010034</dc:identifier>
    	<dc:creator>Eiji Miyoshi</dc:creator>
		<dc:creator>Kenta Moriwaki</dc:creator>
		<dc:creator>Naoko Terao</dc:creator>
		<dc:creator>Cheng-Cheng Tan</dc:creator>
		<dc:creator>Mika Terao</dc:creator>
		<dc:creator>Tsutomu Nakagawa</dc:creator>
		<dc:creator>Hitoshi Matsumoto</dc:creator>
		<dc:creator>Shinichiro Shinzaki</dc:creator>
		<dc:creator>Yoshihiro Kamada</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/23">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 23-33: A New Method to Determine Antigen-Specific CD8+ T Cell Activity in Vivo by Hydrodynamic Injection]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/23</link>
	<description>Hydrodynamic tail vein (HTV) delivery is a simple and rapid tail vein injection method of a high volume of naked plasmid DNA resulting in high levels of foreign gene expression in organs, especially the liver. Compared to other organs, HTV delivery results in more than a 1000-fold higher transgene expression in liver. After being bitten by malaria-infected mosquitoes, malaria parasites transiently infect the host liver and form the liver stages. The liver stages are known to be the key target for CD8+ T cells that mediate protective anti-malaria immunity in an animal model. Therefore, in this study, we utilized the HTV delivery technique as a tool to determine the in vivo cytotoxic effect of malaria antigen-specific CD8+ T cells. Two weeks after mice were immunized with recombinant adenoviruses expressing malarial antigens, the immunized mice as well as naïve mice were challenged by HTV delivery of naked plasmid DNA co-encoding respective antigen together with luciferase using dual promoters. Three days after the HTV challenge, non-invasive whole-body bioluminescent imaging was performed. The images demonstrate in vivo activity of CD8+ T cells against malaria antigen-expressing cells in liver.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2012-01-05</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2010023</prism:doi>
	<prism:startingPage>23</prism:startingPage>
		<prism:endingPage>33</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[A New Method to Determine Antigen-Specific CD8+ T Cell Activity in Vivo by Hydrodynamic Injection]]></dc:title>
    <dc:date>2012-01-05</dc:date>
	<dc:identifier>doi: 10.3390/biom2010023</dc:identifier>
    	<dc:creator>Urvashi Rai</dc:creator>
		<dc:creator>Jing Huang</dc:creator>
		<dc:creator>Satish Mishra</dc:creator>
		<dc:creator>Xiangming Li</dc:creator>
		<dc:creator>Takayuki Shiratsuchi</dc:creator>
		<dc:creator>Moriya Tsuji</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/2/1/1">
	<title><![CDATA[Biomolecules, Vol. 2, Pages 1-22: Exploring the Optimal Strategy to Predict Essential Genes in Microbes]]></title>
	<link>http://www.mdpi.com/2218-273X/2/1/1</link>
	<description>Accurately predicting essential genes is important in many aspects of biology, medicine and bioengineering. In previous research, we have developed a machine learning based integrative algorithm to predict essential genes in bacterial species. This algorithm lends itself to two approaches for predicting essential genes: learning the traits from known essential genes in the target organism, or transferring essential gene annotations from a closely related model organism. However, for an understudied microbe, each approach has its potential limitations. The first is constricted by the often small number of known essential genes. The second is limited by the availability of model organisms and by evolutionary distance. In this study, we aim to determine the optimal strategy for predicting essential genes by examining four microbes with well-characterized essential genes. Our results suggest that, unless the known essential genes are few, learning from the known essential genes in the target organism usually outperforms transferring essential gene annotations from a related model organism. In fact, the required number of known essential genes is surprisingly small to make accurate predictions. In prokaryotes, when the number of known essential genes is greater than 2% of total genes, this approach already comes close to its optimal performance. In eukaryotes, achieving the same best performance requires over 4% of total genes, reflecting the increased complexity of eukaryotic organisms. Combining the two approaches resulted in an increased performance when the known essential genes are few. Our investigation thus provides key information on accurately predicting essential genes and will greatly facilitate annotations of microbial genomes.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2011-12-27</prism:publicationDate>
	<prism:volume>2</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom2010001</prism:doi>
	<prism:startingPage>1</prism:startingPage>
		<prism:endingPage>22</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Exploring the Optimal Strategy to Predict Essential Genes in Microbes]]></dc:title>
    <dc:date>2011-12-27</dc:date>
	<dc:identifier>doi: 10.3390/biom2010001</dc:identifier>
    	<dc:creator>Jingyuan Deng</dc:creator>
		<dc:creator>Lirong Tan</dc:creator>
		<dc:creator>Xiaodong Lin</dc:creator>
		<dc:creator>Yao Lu</dc:creator>
		<dc:creator>Long J. Lu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/1/1/48">
	<title><![CDATA[Biomolecules, Vol. 1, Pages 48-62: Development and Application of Multidimensional HPLC Mapping Method for O-linked Oligosaccharides]]></title>
	<link>http://www.mdpi.com/2218-273X/1/1/48</link>
	<description>Glycosylation improves the solubility and stability of proteins, contributes to the structural integrity of protein functional sites, and mediates biomolecular recognition events involved in cell-cell communications and viral infections. The first step toward understanding the molecular mechanisms underlying these carbohydrate functionalities is a detailed characterization of glycan structures. Recently developed glycomic approaches have enabled comprehensive analyses of N-glycosylation profiles in a quantitative manner. However, there are only a few reports describing detailed O-glycosylation profiles primarily because of the lack of a widespread standard method to identify O-glycan structures. Here, we developed an HPLC mapping method for detailed identification of O-glycans including neutral, sialylated, and sulfated oligosaccharides. Furthermore, using this method, we were able to quantitatively identify isomeric products from an in vitro reaction catalyzed by N-acetylglucosamine-6O-sulfotransferases and obtain O-glycosylation profiles of serum IgA as a model glycoprotein.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2011-12-14</prism:publicationDate>
	<prism:volume>1</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom1010048</prism:doi>
	<prism:startingPage>48</prism:startingPage>
		<prism:endingPage>62</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Development and Application of Multidimensional HPLC Mapping Method for O-linked Oligosaccharides]]></dc:title>
    <dc:date>2011-12-14</dc:date>
	<dc:identifier>doi: 10.3390/biom1010048</dc:identifier>
    	<dc:creator>Hirokazu Yagi</dc:creator>
		<dc:creator>Erina Ohno</dc:creator>
		<dc:creator>Sachiko Kondo</dc:creator>
		<dc:creator>Atsuhiro Yoshida</dc:creator>
		<dc:creator>Koichi Kato</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/1/1/32">
	<title><![CDATA[Biomolecules, Vol. 1, Pages 32-47: Ursolic Acid Inhibits Na+/K+-ATPase Activity and Prevents TNF-α-Induced Gene Expression by Blocking Amino Acid Transport and Cellular Protein Synthesis]]></title>
	<link>http://www.mdpi.com/2218-273X/1/1/32</link>
	<description>Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, induce the expression of a wide variety of genes, including intercellular adhesion molecule-1 (ICAM-1). Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) was identified to inhibit the cell-surface ICAM-1 expression induced by pro-inflammatory cytokines in human lung carcinoma A549 cells. Ursolic acid was found to inhibit the TNF-α-induced ICAM-1 protein expression almost completely, whereas the TNF-α-induced ICAM-1 mRNA expression and NF-κB signaling pathway were decreased only partially by ursolic acid. In line with these findings, ursolic acid prevented cellular protein synthesis as well as amino acid uptake, but did not obviously affect nucleoside uptake and the subsequent DNA/RNA syntheses. This inhibitory profile of ursolic acid was similar to that of the Na+/K+-ATPase inhibitor, ouabain, but not the translation inhibitor, cycloheximide. Consistent with this notion, ursolic acid was found to inhibit the catalytic activity of Na+/K+-ATPase. Thus, our present study reveals a novel molecular mechanism in which ursolic acid inhibits Na+/K+-ATPase activity and prevents the TNF-α-induced gene expression by blocking amino acid transport and cellular protein synthesis.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2011-11-07</prism:publicationDate>
	<prism:volume>1</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/biom1010032</prism:doi>
	<prism:startingPage>32</prism:startingPage>
		<prism:endingPage>47</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Ursolic Acid Inhibits Na+/K+-ATPase Activity and Prevents TNF-α-Induced Gene Expression by Blocking Amino Acid Transport and Cellular Protein Synthesis]]></dc:title>
    <dc:date>2011-11-07</dc:date>
	<dc:identifier>doi: 10.3390/biom1010032</dc:identifier>
    	<dc:creator>Tomonobu Yokomichi</dc:creator>
		<dc:creator>Kyoko Morimoto</dc:creator>
		<dc:creator>Nana Oshima</dc:creator>
		<dc:creator>Yuriko Yamada</dc:creator>
		<dc:creator>Liwei Fu</dc:creator>
		<dc:creator>Shigeru Taketani</dc:creator>
		<dc:creator>Masayoshi Ando</dc:creator>
		<dc:creator>Takao Kataoka</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/1/1/3">
	<title><![CDATA[Biomolecules, Vol. 1, Pages 3-31: Comparative Studies of Vertebrate Beta Integrin Genes and Proteins: Ancient Genes in Vertebrate Evolution]]></title>
	<link>http://www.mdpi.com/2218-273X/1/1/3</link>
	<description>Intregins are heterodimeric α- and β-subunit containing membrane receptor proteins which serve various cell adhesion roles in tissue repair, hemostasis, immune response, embryogenesis and metastasis. At least 18 α- (ITA or ITGA) and 8 β-integrin subunits (ITB or ITGB) are encoded on mammalian genomes. Comparative ITB amino acid sequences and protein structures and ITB gene locations were examined using data from several vertebrate genome projects. Vertebrate ITB genes usually contained 13–16 coding exons and encoded protein subunits with ~800 amino acids, whereas vertebrate ITB4 genes contained 36-39 coding exons and encoded larger proteins with ~1800 amino acids. The ITB sequences exhibited several conserved domains including signal peptide, extracellular β-integrin, β-tail domain and integrin β-cytoplasmic domains. Sequence alignments of the integrin β-cytoplasmic domains revealed highly conserved regions possibly for performing essential functions and its maintenance during vertebrate evolution. With the exception of the human ITB8 sequence, the other ITB sequences shared a predicted 19 residue α-helix for this region. Potential sites for regulating human ITB gene expression were identified which included CpG islands, transcription factor binding sites and microRNA binding sites within the 3’-UTR of human ITB genes. Phylogenetic analyses examined the relationships of vertebrate beta-integrin genes which were consistent with four major groups: 1: ITB1, ITB2, ITB7; 2: ITB3, ITB5, ITB6; 3: ITB4; and 4: ITB8 and a common evolutionary origin from an ancestral gene, prior to the appearance of fish during vertebrate evolution. The phylogenetic analyses revealed that ITB4 is the most likely primordial form of the vertebrate β integrin subunit encoding genes, that is the only β subunit expressed as a constituent of the sole integrin receptor ‘α6β4’ in the hemidesmosomes of unicellular organisms.</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2011-08-23</prism:publicationDate>
	<prism:volume>1</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/biom1010003</prism:doi>
	<prism:startingPage>3</prism:startingPage>
		<prism:endingPage>31</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[Comparative Studies of Vertebrate Beta Integrin Genes and Proteins: Ancient Genes in Vertebrate Evolution]]></dc:title>
    <dc:date>2011-08-23</dc:date>
	<dc:identifier>doi: 10.3390/biom1010003</dc:identifier>
    	<dc:creator>Roger S. Holmes</dc:creator>
		<dc:creator>Ujjwal K. Rout</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2218-273X/1/1/1">
	<title><![CDATA[Biomolecules, Vol. 1, Pages 1-2: A Multidisciplinary, Open Access Platform for Research on Biomolecules]]></title>
	<link>http://www.mdpi.com/2218-273X/1/1/1</link>
	<description>I am pleased to introduce Biomolecules, a new journal to report on all aspects of science that focuses on biologically derived substances, from small molecules to complex polymers. Some examples are lipids, carbohydrates, vitamins, hormones, amino acids, nucleotides, peptides, RNA and polysaccharides, but this list is far from exhaustive. Research on biomolecules encompasses multiple fascinating questions. How are biomolecules synthesized and modified? What are their structures and interactions with other biomolecules? How do biomolecules function in biological processes, at the level of organelles, cells, organs, organisms, or even ecosystems? How do biomolecules affect either the organism that produces them or other organisms of the same or different species? How are biomolecules shaped by evolution, and how in turn do they affect cellular phenotypes? What is the systems-level contribution of biomolecules to biological function?</description>

	<prism:publicationName>Biomolecules</prism:publicationName>
	<prism:publicationDate>2011-08-22</prism:publicationDate>
	<prism:volume>1</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:doi>10.3390/biom1010001</prism:doi>
	<prism:startingPage>1</prism:startingPage>
		<prism:endingPage>2</prism:endingPage>
		<prism:issn>2218-273X</prism:issn>
	
	<dc:title><![CDATA[A Multidisciplinary, Open Access Platform for Research on Biomolecules]]></dc:title>
    <dc:date>2011-08-22</dc:date>
	<dc:identifier>doi: 10.3390/biom1010001</dc:identifier>
    	<dc:creator>Jürg Bähler</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
    
<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
